Skip to main content
C

ChemPartner PharmaTech Co., Ltd. — Investor Relations & Filings

Ticker · 300149 Shenzhen Stock Exchange Professional, scientific and technical activities
Filings indexed 2,244 across all filing types
Latest filing 2023-04-26 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300149

About ChemPartner PharmaTech Co., Ltd.

https://www.chempartner.com

ChemPartner PharmaTech Co., Ltd. is a global research and development organization providing comprehensive drug discovery and development services. Operating as a Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO), the company supports pharmaceutical and biotechnology clients through an integrated service platform. Core capabilities include medicinal chemistry, biology, pharmacology, drug metabolism and pharmacokinetics (DMPK), and toxicology. The organization also offers specialized expertise in biologics discovery, protein engineering, and antibody development. ChemPartner facilitates the transition from early-stage research to clinical development through its pharmaceutical development and manufacturing capabilities, utilizing advanced technology to accelerate the discovery and production of novel therapeutic agents.

Recent filings

Filing Released Lang Actions
2022年年度报告摘要(更新前)
Regulatory Filings
2023-04-26 Chinese
独立董事2022年度述职报告(郭志成)
Regulatory Filings
2023-04-26 Chinese
关于2022年度不进行利润分配的专项说明公告
Regulatory Filings
2023-04-26 Chinese
关于召开2022年年度股东大会的通知
Regulatory Filings
2023-04-26 Chinese
关于使用闲置自有资金进行现金管理的公告
Regulatory Filings
2023-04-26 Chinese
监事会决议公告
Regulatory Filings
2023-04-26 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.